Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 98,591 | 85,908 | 58,017 | 78,645 | 0 |
| Cost of Goods | 25,121 | 23,444 | 17,668 | 21,409 | N/A |
| Gross Profit | 73,470 | 62,464 | 40,349 | 57,236 | N/A |
| Operating Expenses | 67,683 | 55,975 | 45,610 | 44,656 | 0 |
| Operating Income | 5,908 | 6,933 | -4,593 | 12,989 | N/A |
| Interest Expense | 2,656 | 1,880 | 2,834 | 2,381 | 0 |
| Other Income | -111 | 3,285 | 1,337 | -83 | 0 |
| Pre-tax Income | 3,141 | 8,338 | -6,090 | 10,525 | 0 |
| Income Tax | 890 | 373 | -110 | 39 | N/A |
| Net Income Continuous | 2,776 | 7,965 | -5,980 | 10,486 | N/A |
| Minority Interests | -525 | -492 | -214 | -458 | N/A |
| Net Income | $2,776 | $8,457 | $-5,766 | $10,944 | $N/A |
| EPS Basic Total Ops | 0.10 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | 0.57 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.10 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | 0.57 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $13,305 | $14,209 | $2,519 | $20,390 | $N/A |